NCT06832553 The Effect of Surgical Incision Drep Use in Endotracheal Tube Fixation
| NCT ID | NCT06832553 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hasan Kalyoncu University |
| Condition | Preterm |
| Study Type | INTERVENTIONAL |
| Enrollment | 110 participants |
| Start Date | 2024-10-15 |
| Primary Completion | 2025-05-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 110 participants in total. It began in 2024-10-15 with a primary completion date of 2025-05-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
It is aimed to minimise both unplanned extubation and skin damage with the surgical incision drep that we will use to fix the endotracheal tube in neonatal preterm infants and to reduce the complications that may develop due to these events. In addition, it is aimed to evaluate the relationship between these parameters by using devices measuring skin moisture, skin pH and Neonatal Skin Condition Assessment Scale in experimental and control groups.
Eligibility Criteria
Inclusion Criteria: * Preterm infants between 28-34 weeks of gestation hospitalized in neonatal intensive care unit, * Intubated infants on invasive mechanical ventilators, * Babies who were orally intubated were included in the study. Exclusion Criteria: * Congenital skin condition, * With circulatory problems, * Congenital anomalies and metabolic disorders, * Small for gestational age (SGA) and large for gestational age (LGA), * Unplanned extubation taking place, * Babies intubated for less than 24 hours will be excluded from the study.
Contact & Investigator
Barış Çelik
PRINCIPAL INVESTIGATOR
Hasan Kalyoncu University
Frequently Asked Questions
Who can join the NCT06832553 clinical trial?
This trial is open to participants of all sexes, aged 28 Weeks or older, up to 34 Weeks, studying Preterm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06832553 currently recruiting?
Yes, NCT06832553 is actively recruiting participants. Contact the research team at c.celikbaris@gmail.com for enrollment information.
Where is the NCT06832553 trial being conducted?
This trial is being conducted at Batman, Turkey (Türkiye).
Who is sponsoring the NCT06832553 clinical trial?
NCT06832553 is sponsored by Hasan Kalyoncu University. The principal investigator is Barış Çelik at Hasan Kalyoncu University. The trial plans to enroll 110 participants.